Clinical Research Directory
Browse clinical research sites, groups, and studies.
6 clinical studies listed.
Filters:
Tundra lists 6 Evaluation clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.
This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.
NCT07444905
Evaluation of a Machine Learning-Based Prediction Strategy for Extrahepatic Metastasis in Hepatocellular Carcinoma
This is a multicenter prospective observational cohort study in patients with hepatocellular carcinoma (HCC) after curative-intent treatment. The study aims to prospectively validate previously developed machine learning-based risk stratification models for extrahepatic metastasis (with a focus on lung and bone metastasis) and to evaluate their potential clinical utility in real-world postoperative surveillance and management pathways. The study does not assign treatments or surveillance strategies to participants. Clinical care is determined by treating physicians according to local practice. The study will assess model performance (including discrimination and calibration), risk stratification ability, and implementation-related outcomes such as model adoption, decision impact, and changes in monitoring intensity or referral pathways. The study will also explore clinical and resource-related outcomes associated with model-informed risk stratification in routine practice.
Gender: All
Ages: 18 Years - 80 Years
Updated: 2026-03-03
1 state
NCT06846879
Evaluation of the Quality of Care in the Emergency Department by Studying the Appropriateness of Hospitalizations
The aim of this study is to develop, study and validate a rigorous and sustainable method for assessing the clinical appropriateness of the decision taken in the Emergency Department to admit or not to admit patients.
Gender: All
Ages: 18 Years - Any
Updated: 2025-08-13
NCT06345352
Evaluation of the Quality of Care in the Emergency Department by Studying the Appropriateness of Admissions of Patients Accessing the Emergency Department (Fondazione IRCCS Ca' Granda Ospedale Maggione Policlinico)
The aim of this study is to develop, study and validate a rigorous and sustainable method for assessing the clinical appropriateness of the decision taken in the Emergency Department to admit or not to admit patients.
Gender: All
Ages: 18 Years - Any
Updated: 2025-02-24
1 state
NCT06345378
Evaluation of the Quality of Care in the Emergency Department by Studying the Appropriateness of Admissions of Patients Accessing the Emergency Department (ASST Papa Giovanni XXIII)
The aim of this study is to develop, study and validate a rigorous and sustainable method for assessing the clinical appropriateness of the decision taken in the Emergency Department to admit or not to admit patients.
Gender: All
Ages: 18 Years - Any
Updated: 2025-02-24
1 state
NCT04676347
Health-care Quality in Semi-intensive Care Units
The main aim of this study is to realize a system of continuous evaluation of healthcare quality in semi-intensive care units.
Gender: All
Updated: 2025-02-24
1 state
NCT06142058
RecistTM Criteria in Evaluating the Efficacy of Targeted Therapy for NSCLC
Investigators established the efficacy evaluation criteria for tumor markers (RecistTM) in the preliminary research. Among patients with advanced non-small cell lung cancer, patients with positive driving genes are more likely to exhibit abnormalities in tumor markers, which suggests that this criteria may be more suitable for evaluating the efficacy of targeted therapy in driving gene positive patients. Moreover, The judgment rules of the prelimary criteria still need further improvement. Therefore, in order to broaden the application scope of the RecistTM criteria, further improve the evaluation rules of RecistTM criteria, and multi-dimensionally confirm the reliability of RecistTM criteria on efficacy evaluation, investigators plan to conduct research on the application of RecistTM criteria in evaluating the efficacy of targeted therapy for advanced non-small cell lung cancer with positive driving genes.
Gender: All
Ages: 18 Years - Any
Updated: 2023-11-21
1 state